Anumana and Pfizer Partner to Enable Early Detection of Underdiagnosed Cardiovascular Disease

Related Articles
Trial demonstrates early AI-guided detection of heart disease in routine practice
Science Daily: Heart disease can take a number of forms, but some types of heart disease, such as asymptomatic low ejection fraction, can be hard to recognize, especially in the…May 05, 2021
Researchers use AI to detect weak heart pump via patients’ Apple Watch ECGs
Medical Xpress: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump. To interpret…May 01, 2022
Tackling Imbalanced Regression in Clinical AI with KDE-weighted Deep Models
Clinical AI systems often include automated analysis of medical time series, such as electrocardiogram (ECG), to serve as valuable diagnostic decision support tools. While many cardiovascular diseases are traditionally measured…June 15, 2025
Anumana’s AI-Driven Low Ejection Fraction ECG-AI Technology Recognized in CMS 2025 OPPS Final Rule, Expanding Access to Advanced Cardiovascular Care
Company’s ECG-AI algorithm enables earlier heart failure detectionNovember 05, 2024


